Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Post by digger144on Aug 30, 2012 12:15am
294 Views
Post# 20277728

Part of the Package...

Part of the Package...

Daniel Racine has been given a substantial incentive package...I believe he will be worth every penny!

The Option Price is at or near todays close...Nice!

One Million more reasons to get the job done!

Digger144

 

Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Aug 27/12 Aug 21/12 Racine, Daniel Direct Ownership Options 50 - Grant of options 1,000,000  
Aug 27/12 Aug 21/12 Racine, Daniel Direct Ownership Options 00 - Opening Balance-Initial SEDI Report    
Aug 24/12 Aug 21/12 Racine, Daniel Direct Ownership Deferred Share Units 00 - Opening Balance-Initial SEDI Report    
Jul 13/12 Jul 9/12 Bird, Howard Michael Direct Ownership Deferred Share Units 56 - Grant of rights 120,000  
Jul 12/12 Jul 9/12 Dawe, Wade K. Direct Ownership Deferred Share Units 56 - Grant of rights 370,000  
Jul 12/12 Jul 9/12 Gross, Michael Direct Ownership Deferred Share Units 56 - Grant of rights 40,000  
Jul 12/12 Jul 9/12 Burgess, Harry Direct Ownership Deferred Share Units 56 - Grant of rights 40,000  
Jul 12/12 Jul 9/12 Kaiser, Marvin Direct Ownership Deferred Share Units 56 - Grant of rights 40,000  
Jul 12/12 Jul 9/12 Gill, Derrick Edwin Direct Ownership Deferred Share Units 56 - Grant of rights 40,000  
Jul 12/12 Jul 9/12 Peat, David W. Direct Ownership Deferred Share Units 56 - Grant of rights 40,000  

 

Bullboard Posts